# Acute E-Cigarette Aerosol Condensate Exposure Disrupts the Transcriptome and Proteome Profiles of Human Bronchial Epithelial BEAS-2B Cells

**Authors:** Sara Trifunovic, Jelena Kušić-Tišma, Katarina Smiljanić, Aleksandra Divac Rankov, Jelena Dinić, Mila Ljujić

PMC · DOI: 10.3390/cells15060525 · 2026-03-16

## TL;DR

This study shows that short-term exposure to e-cigarette aerosol condensates harms human bronchial cells by disrupting their genetic and protein activity, causing cellular stress.

## Contribution

The study reveals novel insights into how e-cigarette aerosol condensates affect cellular homeostasis and proteostasis in bronchial epithelial cells.

## Key findings

- E-cigarette aerosol condensates altered transcriptome and proteome profiles in BEAS-2B cells.
- Nicotine- and flavor-containing condensates caused changes in lipid, lysosome content, and actin formation.
- Exposure induced irreversible protein modifications, indicating harmful effects on cellular function.

## Abstract

The growing popularity of electronic cigarettes (e-cigarettes) necessitates a better understanding of their biological effects. In this study, we aimed to evaluate the effects of e-cigarette aerosol condensates generated from either e-cigarette carrier liquid alone or with e-cigarette liquid with nicotine and flavor on bronchial epithelial cells. BEAS-2B cells were exposed to e-cigarettes for 24 h, and transcriptional and proteomic profiling, including assessment of protein modifications, was performed. Additionally, cell-based assays were used to evaluate mitochondrial function, rate of protein synthesis, lysosomal signal, lipid droplet quantity and actin formation. Our findings reveal that short-term exposure to both types of aerosol condensates altered transcriptome and proteome profiles, disrupting cellular homeostasis in BEAS-2B cells through impaired proteostasis and mitochondrial function in response to both types of condensates. Changes in lipid and lysosome content, as well as a reduction in polymerized actin, were observed with nicotine- and flavor-containing condensate. E-cigarette exposure also induced irreversible protein modifications, including different chemical derivatives (25 out of 49 in nicotine/flavor condensate; 20 out of 48 in nicotine/flavor-free condensate; 4 out of 35 in control), suggesting their particularly harmful effect. Together, these findings point to early-onset cellular stress and impaired lung epithelial fitness caused by acute e-cigarette exposure.

## Linked entities

- **Chemicals:** nicotine (PubChem CID 942)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** H1-4 (H1.4 linker histone, cluster member) [NCBI Gene 3008] {aka H1.4, H1E, H1F4, H1s-4, HIST1H1E, RMNS}, LTA4H (leukotriene A4 hydrolase) [NCBI Gene 4048], VIPR1 (vasoactive intestinal peptide receptor 1) [NCBI Gene 7433] {aka HVR1, II, PACAP-R-2, PACAP-R2, RDC1, V1RG}, MRPL4 (mitochondrial ribosomal protein L4) [NCBI Gene 51073] {aka CGI-28, L4mt, uL4m}, DMBT1 (deleted in malignant brain tumors 1) [NCBI Gene 1755] {aka GP340, SAG, SALSA, muclin}, RPS11 (ribosomal protein S11) [NCBI Gene 6205] {aka S11, uS17}, MRPL21 (mitochondrial ribosomal protein L21) [NCBI Gene 219927] {aka L21mt, MRP-L21, bL21m}, MYH9 (myosin heavy chain 9) [NCBI Gene 4627] {aka BDPLT6, DFNA17, EPSTS, FTNS, MATINS, MHA}, ABCA7 (ATP binding cassette subfamily A member 7) [NCBI Gene 10347] {aka ABCA-SSN, ABCX, AD9}, ARRDC3 (arrestin domain containing 3) [NCBI Gene 57561] {aka TLIMP}, FLNB (filamin B) [NCBI Gene 2317] {aka ABP-278, ABP-280, FH1, FLN-B, FLN1L, LRS1}, ZHX2 (zinc fingers and homeoboxes 2) [NCBI Gene 22882] {aka AFR1, RAF}, PPP1CC (protein phosphatase 1 catalytic subunit gamma) [NCBI Gene 5501] {aka PP-1G, PP1C, PPP1G}, FBLIM1 (filamin binding LIM protein 1) [NCBI Gene 54751] {aka CAL, FBLP-1, FBLP1}, SRSF2 (serine and arginine rich splicing factor 2) [NCBI Gene 6427] {aka PR264, SC-35, SC35, SFRS2, SFRS2A, SRp30b}, VCAN (versican) [NCBI Gene 1462] {aka CSPG2, ERVR, GHAP, PG-M, WGN, WGN1}, ABCA3 (ATP binding cassette subfamily A member 3) [NCBI Gene 21] {aka ABC-C, ABC3, EST111653, LBM180, SMDP3}, EIF3A (eukaryotic translation initiation factor 3 subunit A) [NCBI Gene 8661] {aka EIF3, EIF3S10, P167, TIF32, eIF3-p170, eIF3-theta}, PA2G4 (proliferation-associated 2G4) [NCBI Gene 5036] {aka EBP1, HG4-1, ITAF45, p38-2G4}, SHISA2 (shisa family member 2) [NCBI Gene 387914] {aka C13orf13, PRO28631, TMEM46, WGAR9166, bA398O19.2, hShisa}, RPL34 (ribosomal protein L34) [NCBI Gene 6164] {aka L34, eL34}, NEU1 (neuraminidase 1) [NCBI Gene 4758] {aka NANH, NEU, SIAL1}, Cyp1a1 (cytochrome P450, family 1, subfamily a, polypeptide 1) [NCBI Gene 13076] {aka AHH, AHRR, CP11, CYPIA1, P450-1}, RSAD2 (radical S-adenosyl methionine domain containing 2) [NCBI Gene 91543] {aka SAND, cig33, cig5, vig1}, JAK3 (Janus kinase 3) [NCBI Gene 3718] {aka JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK}, EIF3D (eukaryotic translation initiation factor 3 subunit D) [NCBI Gene 8664] {aka EIF3S7, eIF3-p66, eIF3-zeta}, CYP1A1 (cytochrome P450 family 1 subfamily A member 1) [NCBI Gene 1543] {aka AHH, CP11, CYP1, CYPIA1, P1-450, P450-C}, COA3 (cytochrome c oxidase assembly factor 3) [NCBI Gene 28958] {aka CCDC56, COX25, HSPC009, MC4DN14, MITRAC12, hCOA3}, FLNA (filamin A) [NCBI Gene 2316] {aka ABP-280, ABPX, CSBS, CVD1, FGS2, FLN}, LAP3 (leucine aminopeptidase 3) [NCBI Gene 51056] {aka HEL-S-106, LAP, LAPEP, PEPS}, CYP1B1 (cytochrome P450 family 1 subfamily B member 1) [NCBI Gene 1545] {aka ASGD6, CP1B, CYPIB1, GLC3A, P4501B1}, IL24 (interleukin 24) [NCBI Gene 11009] {aka C49A, FISP, IL10B, MDA7, MOB5, ST16}, NGFR (nerve growth factor receptor) [NCBI Gene 4804] {aka CD271, Gp80-LNGFR, TNFRSF16, p75(NTR), p75NTR}, NARS1 (asparaginyl-tRNA synthetase 1) [NCBI Gene 4677] {aka ASNRS, NARS, NEDMILEG, NEDMILG}, ND2 (NADH dehydrogenase subunit 2) [NCBI Gene 4536] {aka MTND2}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, RPL5 (ribosomal protein L5) [NCBI Gene 6125] {aka L5, MSTP030, PPP1R135, uL18}, ACTN1 (actinin alpha 1) [NCBI Gene 87] {aka BDPLT15}, ALDH3A1 (aldehyde dehydrogenase 3 family member A1) [NCBI Gene 218] {aka ALDH3, ALDHIII}, Cyp21a1 (cytochrome P450, family 21, subfamily a, polypeptide 1) [NCBI Gene 13079] {aka 21-OH, 21OH, 21OHA, 21OHB, CYP21OH-A, Cyp21}, CCT5 (chaperonin containing TCP1 subunit 5) [NCBI Gene 22948] {aka CCT-epsilon, CCTE, HEL-S-69, HSNSP, PNAS-102, TCP-1-epsilon}, SECTM1 (secreted and transmembrane 1) [NCBI Gene 6398] {aka K12, SECTM}, MRPL3 (mitochondrial ribosomal protein L3) [NCBI Gene 11222] {aka COXPD9, MRL3, RPML3, uL3m}, DLC1 (DLC1 Rho GTPase activating protein) [NCBI Gene 10395] {aka ARHGAP7, HP, STARD12, p122-RhoGAP}, SF3B3 (splicing factor 3b subunit 3) [NCBI Gene 23450] {aka RSE1, SAP130, SF3b130, STAF130}, DAP3 (death associated protein 3) [NCBI Gene 7818] {aka DAP-3, MRP-S29, MRPS29, PRLTS7, S29mt, bMRP-10}, RPS6 (ribosomal protein S6) [NCBI Gene 6194] {aka S6, eS6}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, CCT8 (chaperonin containing TCP1 subunit 8) [NCBI Gene 10694] {aka C21orf112, Cctq, D21S246, PRED71}, DIRAS2 (DIRAS family GTPase 2) [NCBI Gene 54769] {aka Di-Ras2}, MX2 (MX dynamin like GTPase 2) [NCBI Gene 4600] {aka MXB}, RHOA (ras homolog family member A) [NCBI Gene 387] {aka ARH12, ARHA, EDFAOB, RHO12, RHOH12}, POSTN (periostin) [NCBI Gene 10631] {aka OSF-2, OSF2, PDLPOSTN, PN}, MCM3 (minichromosome maintenance complex component 3) [NCBI Gene 4172] {aka HCC5, P1-MCM3, P1.h, RLFB}, EIF3I (eukaryotic translation initiation factor 3 subunit I) [NCBI Gene 8668] {aka EIF3S2, PRO2242, TRIP-1, TRIP1, eIF3-beta, eIF3-p36}, NONO (non-POU domain containing octamer binding) [NCBI Gene 4841] {aka MRXS34, NMT55, NRB54, P54, P54NRB, PPP1R114}, EIF3B (eukaryotic translation initiation factor 3 subunit B) [NCBI Gene 8662] {aka EIF3-ETA, EIF3-P110, EIF3-P116, EIF3S9, PRT1}, H1-5 (H1.5 linker histone, cluster member) [NCBI Gene 3009] {aka H1, H1.5, H1B, H1F5, H1s-3, HIST1H1B}, BCAT1 (branched chain amino acid transaminase 1) [NCBI Gene 586] {aka BCATC, BCT1, ECA39, MECA39, PNAS121, PP18}, CCT3 (chaperonin containing TCP1 subunit 3) [NCBI Gene 7203] {aka CCT-gamma, CCTG, NEDSVH, PIG48, TCP-1-gamma, TRIC5}
- **Diseases:** Lung inflammation (MESH:D011014), lung cancer (MESH:D008175), infections (MESH:D007239), injury to (MESH:D014947), PM (MESH:D011488), neurodegenerative disorders (MESH:D019636), Lysosome (MESH:D016464), lung diseases (MESH:D008171), diabetes (MESH:D003920), Mitochondrial dysfunction (MESH:D028361), COPD (MESH:D029424), atherosclerosis (MESH:D050197), neurotoxicity (MESH:D020258), toxicity (MESH:D064420), cancer (MESH:D009369), chronic (MESH:D002908), hypoxia (MESH:D000860), inflammation (MESH:D007249), EC (MESH:D005955), asthma (MESH:D001249)
- **Chemicals:** benzofuran (MESH:C105430), Gln (MESH:D005973), PG (MESH:D019946), 4,4-Difluoro-1,3,5,7,8-Pentamethyl-4-Bora-3a,4a-Diaza-s-Indacene (MESH:C527198), Triton X-100 (MESH:D017830), ethanol (MESH:D000431), benzo(a)pyrene (MESH:D001564), Phalloidin (MESH:D010590), TMRE (MESH:C110932), Met (MESH:D008715), serine (MESH:D012694), glycolipids (MESH:D006017), D0632 (-), trinitrobenzene (MESH:D014301), Glyoxal (MESH:D006037), O-propargyl-puromycin (MESH:C570448), Lipid (MESH:D008055), Carbofuran (MESH:D002235), pyrrolidinone (MESH:D011760), glycerol (MESH:D005990), CS (MESH:D002586), arginine (MESH:D001120), paraformaldehyde (MESH:C003043), SDS (MESH:D012967), nicotine (MESH:D009538), phospholipids (MESH:D010743), Asn (MESH:D001216), Cys (MESH:D003545), acetaldehyde (MESH:D000079), 3-NT (MESH:C002744), alkyne (MESH:D000480), valine (MESH:D014633), DMSO (MESH:D004121), azide (MESH:D001386), Peptides (MESH:D010455), sulfonamide (MESH:D013449), lysine (MESH:D008239), silicate (MESH:D017640), acetonitrile (MESH:C032159), formaldehyde (MESH:D005557), JC-1 (MESH:C068624), Hoechst 33342 (MESH:C017807), copper (MESH:D003300), formic acid (MESH:C030544), isoindole (MESH:D054833), puromycin (MESH:D011691), proline (MESH:D011392), polyacrylamide (MESH:C016679), MTT (MESH:C070243), carbon monoxide (MESH:D002248), dithiothreitol (MESH:D004229), dansyl chloride (MESH:C029038), water (MESH:D014867), LysoTracker (MESH:C493330), PAHs (MESH:D011084), naphthalene-2,3-dicarboxaldehyde (MESH:C027717), CO2 (MESH:D002245), iodoacetamide (MESH:D007460), MTT formazan (MESH:C079782), ATP (MESH:D000255)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** alveolar type 2 — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_VR37), V79 — Cricetulus griseus (Chinese hamster), Spontaneously immortalized cell line (CVCL_2234), T669 — Homo sapiens (Human), Usher syndrome, Induced pluripotent stem cell (CVCL_LF22), BEAS-2B — Homo sapiens (Human), Transformed cell line (CVCL_0168), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13025378/full.md

---
Source: https://tomesphere.com/paper/PMC13025378